Intra-Cellular Therapies Inc. buy Robert W. Baird
Start price
03.01.24
/
50%
€64.00
Target price
03.01.25
€75.98
Performance (%)
-3.13%
Price
21.05.24
€62.00
Summary
This prediction is currently active. With a performance of -3.13%, the BUY prediction by Robert_W__Baird is trending in the wrong direction. This prediction currently runs until 03.01.25. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intra-Cellular Therapies Inc. | 1.639% | 1.639% |
| iShares Core DAX® | -0.268% | 5.471% |
| iShares Nasdaq 100 | 1.854% | 7.851% |
| iShares Nikkei 225® | 0.284% | 1.729% |
| iShares S&P 500 | 1.178% | 5.269% |
Comments by Robert_W__Baird for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $83.00 price target on the stock.
Ratings data for ITCI provided by MarketBeat
Stopped prediction by Robert_W__Baird for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€68.50
18.04.24
18.04.24
€96.53
18.04.25
18.04.25
-9.49%
21.05.24
21.05.24
